BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 14882450)

  • 41. [Disorders of copper and amino acid metabolism in hepato-cerebral degeneration and their treatment with BAL].
    STEGER J; STEGER R
    Dtsch Z Nervenheilkd; 1954; 172(4):321-51. PubMed ID: 14365436
    [No Abstract]   [Full Text] [Related]  

  • 42. The long term management of hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH; STERNLIEB I
    Am J Med; 1960 Aug; 29():316-33. PubMed ID: 13747430
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical spectrum of Wilson's disease (hepatolenticular degeneration).
    Dobyns WB; Goldstein NP; Gordon H
    Mayo Clin Proc; 1979 Jan; 54(1):35-42. PubMed ID: 759736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; ROSEVEAR JW; McGUCKIN WF
    Neurology; 1962 Apr; 12():231-44. PubMed ID: 13899920
    [No Abstract]   [Full Text] [Related]  

  • 45. British anti-Lewisite (dimercaprol): an amazing history.
    Vilensky JA; Redman K
    Ann Emerg Med; 2003 Mar; 41(3):378-83. PubMed ID: 12605205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current treatment of hepatolenticular degenerescence].
    Faur A; Păsculescu G; Dörl F
    Med Interna (Bucur); 1972 Dec; 24(12):1413-9. PubMed ID: 4632206
    [No Abstract]   [Full Text] [Related]  

  • 47. The treatment of hepatolenticular degeneration.
    CUMINGS JN
    Proc R Soc Med; 1959 Jan; 52(1):62-4. PubMed ID: 13623852
    [No Abstract]   [Full Text] [Related]  

  • 48. [2 CASES OF WILSON'S DISEASE, WITH SPECIAL REFERENCE TO THERAPY AND THE DANGER OF FURTHER PROGRESS OF THE DISEASE].
    SOTODA S; YAMAKI Y; MIYAKO M
    Chiryo; 1964; 46():643-7. PubMed ID: 14126932
    [No Abstract]   [Full Text] [Related]  

  • 49. [WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION, DYSTROPHIA HEPATOCEREBRALIS) DIAGNOSIS, TREATMENT AND DISPENSARY OBSERVATION. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015].
    Golovanova EV; Lazebnik LB; Konev YV; Shaposhnikova NA
    Eksp Klin Gastroenterol; 2015; (7):108-11. PubMed ID: 26817129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [OUR EXPERIENCE IN THE TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINE].
    BOUDIN G; PEPIN B; LAURAS A; BARRAINE R
    Rev Neurol (Paris); 1963 Jul; 109():82-6. PubMed ID: 14091678
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of hepatolenticular degeneration (Wilson's disease).
    Traugh G
    Arch Phys Med Rehabil; 1971 Mar; 52(3):126-9. PubMed ID: 5575151
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatolenticular degeneration: a new metabolic disease].
    BOUDIN G; PEPIN B
    Presse Med (1893); 1954 Feb; 62(12):243-5. PubMed ID: 13145588
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 54. STUDY OF WILSON'S DISEASE IN TAIWAN.
    TU JB; HUNG TP; BLACKWELL RQ; WATTEN RH
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1962 Sep; 61():898-912. PubMed ID: 14067922
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapy of Wilson's disease].
    IWANOWSKI L
    Neurol Neurochir Psychiatr Pol; 1954; 4(5):515-20. PubMed ID: 14356319
    [No Abstract]   [Full Text] [Related]  

  • 56. [Advances in the study of hepatolenticular degeneration].
    Liu DK; Li NZ; Chen XZ; Yang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):248-51. PubMed ID: 3908020
    [No Abstract]   [Full Text] [Related]  

  • 57. [CURRENT ASPECTS OF WILSON'S DISEASE].
    PETIT H
    Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920
    [No Abstract]   [Full Text] [Related]  

  • 58. WILSON'S DISEASE.
    BUMBALO TS; STAUB RU; VILLANUEVA OQ
    GP; 1964 Jun; 29():89-93. PubMed ID: 14143829
    [No Abstract]   [Full Text] [Related]  

  • 59. WILSON'S DISEASE AS A GASTROENTEROLOGIC PROBLEM.
    STERNLIEB I
    Am J Gastroenterol; 1964 Sep; 42():264-70. PubMed ID: 14202497
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of estrogen therapy on ceruloplasmin concentration in a man with Wilson's disease.
    RUSS EM; RAYMUNT J; PILLAR S
    J Clin Endocrinol Metab; 1957 Jul; 17(7):908-9. PubMed ID: 13439005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.